Thomas Stranzl

2.1k total citations
26 papers, 1.5k citations indexed

About

Thomas Stranzl is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Thomas Stranzl has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in Thomas Stranzl's work include Drug Transport and Resistance Mechanisms (8 papers), Allergic Rhinitis and Sensitization (5 papers) and Mass Spectrometry Techniques and Applications (4 papers). Thomas Stranzl is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Allergic Rhinitis and Sensitization (5 papers) and Mass Spectrometry Techniques and Applications (4 papers). Thomas Stranzl collaborates with scholars based in Austria, Denmark and United States. Thomas Stranzl's co-authors include Morten Nielsen, Claus Lundegaard, Mette Voldby Larsen, Karl Mechtler, Martin Filipits, Gudrun Pohl, Robert Pirker, Peter Pichler, Viktoria Dorfer and Thomas Taus and has published in prestigious journals such as Blood, PLoS ONE and Analytical Chemistry.

In The Last Decade

Thomas Stranzl

26 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Stranzl Austria 18 886 436 238 233 231 26 1.5k
Gerhard Dürnberger Austria 15 1.4k 1.6× 212 0.5× 797 3.3× 265 1.1× 294 1.3× 26 2.2k
Melanie Planyavsky Austria 12 1.3k 1.5× 246 0.6× 964 4.1× 145 0.6× 362 1.6× 14 2.2k
Chance John Luckey United States 21 892 1.0× 260 0.6× 923 3.9× 219 0.9× 232 1.0× 42 1.8k
Evangelia Komisopoulou United States 15 791 0.9× 292 0.7× 616 2.6× 75 0.3× 134 0.6× 16 1.9k
Peter J. Welch United States 18 1.1k 1.3× 551 1.3× 108 0.5× 49 0.2× 170 0.7× 24 1.7k
Henrik Gårdsvoll Denmark 30 891 1.0× 631 1.4× 289 1.2× 199 0.9× 431 1.9× 53 2.4k
Albrecht Gruhler Denmark 16 1.4k 1.6× 238 0.5× 433 1.8× 548 2.4× 141 0.6× 21 2.2k
Michael G. Mulkerrin United States 18 1.6k 1.8× 315 0.7× 569 2.4× 101 0.4× 159 0.7× 24 2.7k
Larissa Belov Australia 16 759 0.9× 192 0.4× 191 0.8× 48 0.2× 52 0.2× 37 1.1k
Kenneth W. Harder Canada 26 1.5k 1.7× 504 1.2× 1.4k 6.0× 51 0.2× 192 0.8× 49 2.9k

Countries citing papers authored by Thomas Stranzl

Since Specialization
Citations

This map shows the geographic impact of Thomas Stranzl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Stranzl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Stranzl more than expected).

Fields of papers citing papers by Thomas Stranzl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Stranzl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Stranzl. The network helps show where Thomas Stranzl may publish in the future.

Co-authorship network of co-authors of Thomas Stranzl

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Stranzl. A scholar is included among the top collaborators of Thomas Stranzl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Stranzl. Thomas Stranzl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blaiss, Michael S., Stephen R. Durham, David I. Bernstein, et al.. (2024). Sublingual Tablet Immunotherapy Improves Quality of Life in Adults With Allergic Rhinoconjunctivitis. The Journal of Allergy and Clinical Immunology In Practice. 12(6). 1520–1529.e5. 3 indexed citations
2.
Stranzl, Thomas, David I. Bernstein, Tomokazu Matsuoka, et al.. (2024). Consistent efficacy and safety of sublingual immunotherapy tablets across allergens and geographic regions. Allergy and Asthma Proceedings. 45(4). 232–239. 2 indexed citations
3.
Hoof, Ilka, Klaus Bønnelykke, Thomas Stranzl, et al.. (2023). Genetic and T2 biomarkers linked to the efficacy of HDM sublingual immunotherapy in asthma. Thorax. 79(4). 332–339. 7 indexed citations
4.
Hoof, Ilka, Véronique Schulten, Janice A. Layhadi, et al.. (2019). Allergen-specific IgG+ memory B cells are temporally linked to IgE memory responses. Journal of Allergy and Clinical Immunology. 146(1). 180–191. 56 indexed citations
5.
Beveridge, Rebecca, David M. Hollenstein, Evelyn Rampler, et al.. (2018). Structural prediction of protein models using distance restraints derived from cross-linking mass spectrometry data. Nature Protocols. 13(3). 478–494. 50 indexed citations
6.
Stranzl, Thomas, Mette Voldby Larsen, Ole Lund, Morten Nielsen, & Søren Brunak. (2012). The Cancer Exome Generated by Alternative mRNA Splicing Dilutes Predicted HLA Class I Epitope Density. PLoS ONE. 7(9). e38670–e38670. 14 indexed citations
7.
Stranzl, Thomas, Mette Voldby Larsen, Claus Lundegaard, & Morten Nielsen. (2010). NetCTLpan: pan-specific MHC class I pathway epitope predictions. Immunogenetics. 62(6). 357–368. 285 indexed citations
8.
Rix, Lily L. Remsing, Uwe Rix, Jacques Colinge, et al.. (2008). Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells. Leukemia. 23(3). 477–485. 228 indexed citations
9.
Rudas, Margaretha, Martin Filipits, Susanne Taucher, et al.. (2003). Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy. Breast Cancer Research and Treatment. 81(2). 149–157. 62 indexed citations
10.
Pohl, Gudrun, Margaretha Rudas, Susanne Taucher, et al.. (2003). Expression of Cell Cycle Regulatory Proteins in Breast Carcinomas Before and After Preoperative Chemotherapy. Breast Cancer Research and Treatment. 78(1). 97–103. 48 indexed citations
11.
Stranzl, Thomas, et al.. (2003). Expression of folylpolyglutamyl synthetase predicts poor response to methotrexate therapy in patients with rheumatoid arthritis.. PubMed. 21(1). 27–32. 19 indexed citations
12.
Pohl, Gudrun, Thomas Stranzl, D. Depisch, et al.. (2001). Expression of the lung resistance protein in primary colorectal carcinomas.. PubMed. 21(1A). 201–4. 3 indexed citations
13.
Pohl, Gudrun, et al.. (2000). Expression of the lung resistance protein (LRP) in primary breast cancer.. PubMed. 19(6B). 5051–5. 18 indexed citations
14.
Filipits, Martin, Thomas Stranzl, Gudrun Pohl, et al.. (2000). Drug resistance factors in acute myeloid leukemia: a comparative analysis. Leukemia. 14(1). 68–76. 47 indexed citations
15.
Filipits, Martin, R. Malayeri, Gudrun Pohl, et al.. (2000). Expression of the multidrug resistance protein (MRP1) in breast cancer.. PubMed. 19(6B). 5043–9. 26 indexed citations
16.
Filipits, Martin, Johannes Drach, Gudrun Pohl, et al.. (1999). Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma.. PubMed. 5(9). 2426–30. 39 indexed citations
17.
Filipits, Martin, Thomas Stranzl, Gudrun Pohl, et al.. (1999). MRP Expression in Acute Myeloid Leukemia. Advances in experimental medicine and biology. 457. 141–150. 26 indexed citations
18.
Pirker, Robert, Gudrun Pohl, Thomas Stranzl, et al.. (1999). The Lung Resistance Protein (LRP) Predicts Poor Outcome in Acute Myeloid Leukemia. Advances in experimental medicine and biology. 457. 133–139. 14 indexed citations
19.
Filipits, Martin, Gudrun Pohl, Thomas Stranzl, et al.. (1998). Expression of the Lung Resistance Protein Predicts Poor Outcome in De Novo Acute Myeloid Leukemia. Blood. 91(5). 1508–1513. 90 indexed citations
20.
Filipits, Martin, Gudrun Pohl, Thomas Stranzl, et al.. (1998). Expression of the Lung Resistance Protein Predicts Poor Outcome in De Novo Acute Myeloid Leukemia. Blood. 91(5). 1508–1513. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerhard Dürnberger Breakdown of academic impact, for papers by Melanie Planyavsky Breakdown of academic impact, for papers by Chance John Luckey Breakdown of academic impact, for papers by Evangelia Komisopoulou Breakdown of academic impact, for papers by Peter J. Welch Breakdown of academic impact, for papers by Henrik Gårdsvoll Breakdown of academic impact, for papers by Albrecht Gruhler Breakdown of academic impact, for papers by Michael G. Mulkerrin Breakdown of academic impact, for papers by Larissa Belov Breakdown of academic impact, for papers by Kenneth W. Harder
Rankless by CCL
2026